ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 236 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,213,000 | +3.5% | 1,310,004 | -0.7% | 0.01% | +25.0% |
Q2 2023 | $16,629,000 | -3.4% | 1,319,746 | +0.1% | 0.00% | -20.0% |
Q1 2023 | $17,206,000 | -24.9% | 1,318,447 | +1.5% | 0.01% | -28.6% |
Q4 2022 | $22,923,000 | +15.4% | 1,299,585 | -0.4% | 0.01% | +16.7% |
Q3 2022 | $19,861,000 | +1.3% | 1,304,161 | -1.4% | 0.01% | 0.0% |
Q2 2022 | $19,613,000 | -33.8% | 1,322,492 | +0.5% | 0.01% | -14.3% |
Q1 2022 | $29,647,000 | +33.6% | 1,316,473 | +9.5% | 0.01% | +40.0% |
Q4 2021 | $22,187,000 | +36.2% | 1,202,533 | -1.3% | 0.01% | +25.0% |
Q3 2021 | $16,294,000 | -28.4% | 1,218,655 | -0.9% | 0.00% | -33.3% |
Q2 2021 | $22,760,000 | +20.9% | 1,229,677 | -1.9% | 0.01% | +20.0% |
Q1 2021 | $18,823,000 | -6.5% | 1,253,601 | -10.0% | 0.01% | -16.7% |
Q4 2020 | $20,121,000 | +73.4% | 1,393,371 | -2.2% | 0.01% | +50.0% |
Q3 2020 | $11,602,000 | +19.5% | 1,425,401 | -0.6% | 0.00% | 0.0% |
Q2 2020 | $9,706,000 | +1.5% | 1,433,501 | +5.6% | 0.00% | -20.0% |
Q1 2020 | $9,562,000 | -26.1% | 1,358,092 | +3.0% | 0.01% | 0.0% |
Q4 2019 | $12,944,000 | -2.7% | 1,318,767 | +8.8% | 0.01% | 0.0% |
Q3 2019 | $13,305,000 | -5.5% | 1,211,659 | +0.1% | 0.01% | -16.7% |
Q2 2019 | $14,081,000 | +19.3% | 1,210,778 | -2.1% | 0.01% | +20.0% |
Q1 2019 | $11,802,000 | -0.1% | 1,237,164 | +0.9% | 0.01% | -16.7% |
Q4 2018 | $11,818,000 | -40.5% | 1,225,984 | -12.1% | 0.01% | -25.0% |
Q3 2018 | $19,874,000 | +22.5% | 1,394,643 | +3.1% | 0.01% | +14.3% |
Q2 2018 | $16,226,000 | -18.2% | 1,352,136 | -15.8% | 0.01% | -22.2% |
Q1 2018 | $19,836,000 | -17.3% | 1,606,106 | -2.6% | 0.01% | -18.2% |
Q4 2017 | $23,999,000 | +43.8% | 1,649,424 | +40.6% | 0.01% | +37.5% |
Q3 2017 | $16,691,000 | +36.9% | 1,172,959 | +22.8% | 0.01% | +33.3% |
Q2 2017 | $12,189,000 | +54.3% | 955,183 | +53.3% | 0.01% | +50.0% |
Q1 2017 | $7,902,000 | +26.8% | 623,216 | +2.1% | 0.00% | +33.3% |
Q4 2016 | $6,233,000 | -67.7% | 610,532 | -58.3% | 0.00% | -72.7% |
Q3 2016 | $19,284,000 | +151.8% | 1,464,180 | +142.9% | 0.01% | +120.0% |
Q2 2016 | $7,657,000 | +2.0% | 602,874 | +6.1% | 0.01% | 0.0% |
Q1 2016 | $7,509,000 | -10.0% | 568,404 | +4.8% | 0.01% | 0.0% |
Q4 2015 | $8,346,000 | +21.9% | 542,620 | -1.8% | 0.01% | 0.0% |
Q3 2015 | $6,849,000 | -25.1% | 552,328 | -17.3% | 0.01% | -16.7% |
Q2 2015 | $9,141,000 | +23.9% | 668,205 | +8.4% | 0.01% | +20.0% |
Q1 2015 | $7,375,000 | -10.0% | 616,617 | -3.9% | 0.01% | 0.0% |
Q4 2014 | $8,191,000 | -10.6% | 641,410 | -6.0% | 0.01% | -16.7% |
Q3 2014 | $9,158,000 | -17.0% | 682,666 | -0.7% | 0.01% | -14.3% |
Q2 2014 | $11,036,000 | -17.5% | 687,604 | -7.4% | 0.01% | -30.0% |
Q1 2014 | $13,384,000 | +20.7% | 742,289 | +3.5% | 0.01% | +25.0% |
Q4 2013 | $11,088,000 | +5.2% | 717,220 | +1.2% | 0.01% | 0.0% |
Q3 2013 | $10,540,000 | +41.3% | 708,824 | +22.9% | 0.01% | +33.3% |
Q2 2013 | $7,460,000 | – | 576,520 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |